BOSTON, MA—Rare, postinfarction ventricular septal defects (VSDs), which saw a worrisome resurgence during the COVID-19 pandemic, can effectively be treated surgically or percutaneously, with similar ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Based on a few hundred cases, 5-year all-cause mortality was approximately 60% between patients assigned an initial management strategy of surgery and those undergoing percutaneous treatment (log-rank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results